Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy. - Wikidata - awgldk - TriplyDB

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.

http://www.wikidata.org/entity/Q33843181

about

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy How Can New Imaging Modalities Help in the Practice of Radiology?Review of Journal of Cardiovascular Magnetic Resonance 2011.Review of journal of cardiovascular magnetic resonance 2010.The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease.Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: a marker of advanced disease and electrical myocardial instability.Walking with Gianluca Di Bella during the development of clinical cardiac imaging.Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.Assessment of atrial diastolic function in patients with hypertrophic cardiomyopathy by cine magnetic resonance imaging.Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: the importance of clinical context.A fast and effective method to assess myocardial hyperemia in acute myocarditis by magnetic resonance.RE: Multi-Parameter CMR Approach in Acute Myocarditis to Improve Diagnosis and Prognostic Stratification.Progression of myocardial fibrosis and functional clinical status in Hypertrophic Cardiomyopathy: a study with cardiac magnetic resonance.

P2860

Q26999424-810E4146-351C-45AF-B21B-02BE1992D24B Q30364437-6AE61110-050D-44C1-9830-FC4FFC349656 Q30459937-BEB3DEC1-768A-4F23-98AA-32BEADC33338 Q30474025-CDF91E12-CFC5-48F3-AE9D-F5C3822DDC24 Q30847650-9F0960E8-F4DF-4F71-915B-35AE32E6D693 Q34428462-35EEC4E1-5F89-4477-8F07-00BE020C2D4F Q41332320-74F44E42-D660-47E5-BD58-277FFBF6AAE7 Q43535198-945A938F-E0A5-4CFE-9219-58B607A0C238 Q48684816-F331A523-4E51-46A9-8351-B30D0A4A83F9 Q50138783-B750CEB6-3481-494A-8430-0F5A358F333A Q53082493-58962497-34FD-4329-AE8D-4E15896C6A45 Q55057781-1F8E7C48-E119-4D06-BD7B-A2BF6739AEA5 Q55507093-3DD58BA3-C836-4C30-BB20-122356B28E1F

P2860

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.

http://www.wikidata.org/entity/Q33843181

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.

@ast

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.

@en

type

label

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.

@ast

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.

@en

prefLabel

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.

@ast

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.

@en

P1433

Q33843181-C8560FD3-5CA9-41C9-B767-3DC395698B9D

P1476

Q33843181-4B2D21B1-2C5F-44B5-A3D7-8F034EFF398C

P2093

Q33843181-248AF440-9BA6-446D-A0F8-CA3EAACB0590

Q33843181-3D6E5517-DBCE-405F-9C7F-E07AF4568781

Q33843181-3EC7E7D8-8778-4E4A-B4C3-5CA86B190A78

Q33843181-4F6D8976-D72E-48E6-BC98-3CC17DAEA6F1

Q33843181-80EA36FD-D4CF-4401-9D70-AD212C1A746F

Q33843181-BC24D1A0-3F8F-4796-8C98-8FD5A73C6645

Q33843181-C156D105-4F72-46A1-96A9-96AB0CEB6750

Q33843181-F5205F48-68DE-4F38-9302-A6B5A2BB2CC9

P2860

Q33843181-1426D6E1-C3AA-4850-8F6E-994C73CFE909

Q33843181-28AF6246-AE8B-4CEF-8D04-911F4F17784D

Q33843181-301C6699-B96D-475D-B552-FD9A29A3E7A3

Q33843181-3CDCDE47-3FA7-499E-B03A-0CA6BE75E409

Q33843181-5E580A13-B006-46B6-9239-786BC9A02E2B

Q33843181-77E41AEF-52A6-44BE-B274-9BA4E93B59F5

Q33843181-B3EAA324-D51B-4C82-B028-0C4EAB6041D5

Q33843181-C050982F-7A9C-4E9B-A862-A7B48C3DF849

Q33843181-ED548FD3-7474-4984-8B67-B1947A8B459D

Q33843181-F353571A-EA3C-4ACE-B5DB-B9155EDC7C25

P2888

Q33843181-F69A0F66-EA1D-4307-912C-573CECF8AB75

P304

Q33843181-DC680D67-B3B6-45C2-A194-D800E51721D3

P31

Q33843181-F1A7EB26-384F-4767-827A-9FD9915E9BD7

P356

Q33843181-4D6ADB94-151A-454A-8110-B21592CE0FA8

P478

Q33843181-D7D3832D-825A-429A-8810-912F0414872A

P577

Q33843181-30DA44CC-BB2E-4A3E-A915-9FEB34BF4CDF

P5875

Q33843181-9E29723C-AFBF-4CB6-884E-643B25AAC3EB

P6179

Q33843181-098F2E17-A677-43F8-B34F-BB1151E9A314

P698

Q33843181-13A9BFAC-E862-4577-8620-F99D850E888F

P932

Q33843181-2E472045-8C27-465C-9331-FA7FFBB66B4A

P356

1532-429X-12-21

P1433

Journal of Cardiovascular Magnetic Resonance

P1476

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.

@en

P2093

Alessandro Pingitore

http://www.w3.org/2001/XMLSchema#string

Elisabetta Strata

http://www.w3.org/2001/XMLSchema#string

Francesco Formisano

http://www.w3.org/2001/XMLSchema#string

Gianluca Di Bella

http://www.w3.org/2001/XMLSchema#string

Giovanni Donato Aquaro

http://www.w3.org/2001/XMLSchema#string

Massimo Lombardi

http://www.w3.org/2001/XMLSchema#string

P Spirito

http://www.w3.org/2001/XMLSchema#string

Vincenzo Positano

http://www.w3.org/2001/XMLSchema#string

P2860

Maximum likelihood estimation of signal amplitude and noise variance from MR data.

Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.

The Rician distribution of noisy MRI data.

The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.

Signal-to-noise measurements in magnitude images from NMR phased arrays

Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR.

Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity.

Original report. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging.

Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance

P2888

1532-429x-12-21

P304

21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1532-429X-12-21

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43072604

http://www.w3.org/2001/XMLSchema#string

P6179

1033994354

http://www.w3.org/2001/XMLSchema#string

P698

20374627

http://www.w3.org/2001/XMLSchema#string

P932

2867984

http://www.w3.org/2001/XMLSchema#string